Literature DB >> 28093015

Prevalence and incidence of doctor-diagnosed Dupuytren's disease: a population-based study.

J Nordenskjöld1,2, M Englund3, C Zhou3, I Atroshi1,2.   

Abstract

The prevalence and incidence of doctor-diagnosed Dupuytren's disease in the general population is unknown. From the healthcare register for Skåne region (population 1.3 million) in southern Sweden, we identified all residents aged ⩾20 years (on 31 December 2013), who 1998 to 2013 had consulted a doctor and received the diagnosis Dupuytren's disease (International Classification of Diseases 10th Revision code M720). During the 16 years, 7207 current residents (72% men) had been diagnosed with Dupuytren's disease; the prevalence among men was 1.35% and among women 0.5%. Of all people diagnosed, 56% had received treatment (87% fasciectomy). In 2013, the incidence of first-time doctor-diagnosed Dupuytren's disease among men was 14 and among women five per 10,000. The annual incidence among men aged ⩾50 years was 27 per 10,000. Clinically important Dupuytren's disease is common in the general population. LEVEL OF EVIDENCE: III.

Entities:  

Keywords:  Dupuytren’s disease; collagenase; fasciectomy; fasciotomy; incidence; prevalence

Mesh:

Substances:

Year:  2017        PMID: 28093015     DOI: 10.1177/1753193416687914

Source DB:  PubMed          Journal:  J Hand Surg Eur Vol        ISSN: 0266-7681


  8 in total

1.  Dupuytren's Contracture - Current Concepts.

Authors:  Agneish Dutta; Gihan Jayasinghe; Saurabh Deore; Karim Wahed; Kavynash Bhan; Nik Bakti; Bijayendra Singh
Journal:  J Clin Orthop Trauma       Date:  2020-04-15

Review 2.  Dupuytren's Disease-Etiology and Treatment.

Authors:  Mike Ruettermann; Robert Michael Hermann; Karl Khatib-Chahidi; Paul M N Werker
Journal:  Dtsch Arztebl Int       Date:  2021-11-19       Impact factor: 8.251

3.  Metabolic factors and the risk of Dupuytren's disease: data from 30,000 individuals followed for over 20 years.

Authors:  Mattias Rydberg; Malin Zimmerman; Jin Persson Löfgren; Anders Gottsäter; Peter M Nilsson; Olle Melander; Lars B Dahlin
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

4.  Clinical and morphological outcomes after percutaneous needle fasciotomy in Dupuytren's disease according to the contracture severity.

Authors:  Cristian Trâmbiţaş; Alina Dia Trâmbiţaş-Miron; Andrei Marian Feier; Octav Marius Russu; Dorin Constantin Dorobanţu; Klara Brînzaniuc
Journal:  Rom J Morphol Embryol       Date:  2021 Jul-Sep       Impact factor: 0.833

5.  The Epidemiology of Dupuytren's Disease in Korea: a Nationwide Population-based Study.

Authors:  Kwang-Hyun Lee; Joo-Hak Kim; Chang-Hun Lee; Sung-Jae Kim; Young-Hoon Jo; Myungsub Lee; Wan-Sun Choi
Journal:  J Korean Med Sci       Date:  2018-06-18       Impact factor: 2.153

6.  Examiners' influence on the measured active and passive extension deficit in finger joints affected by Dupuytren disease.

Authors:  Jesper Nordenskjöld; Stina Brodén; Isam Atroshi
Journal:  BMC Med Res Methodol       Date:  2018-10-29       Impact factor: 4.615

7.  Collagenase injections for Dupuytren disease: 3-year treatment outcomes and predictors of recurrence in 89 hands.

Authors:  Jesper Nordenskjöld; Anna Lauritzson; Anna Åkesson; Isam Atroshi
Journal:  Acta Orthop       Date:  2019-09-10       Impact factor: 3.717

8.  The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis.

Authors:  Nader Salari; Mohammadbagher Heydari; Masoud Hassanabadi; Mohsen Kazeminia; Nikzad Farshchian; Mehrdad Niaparast; Yousef Solaymaninasab; Masoud Mohammadi; Shamarina Shohaimi; Alireza Daneshkhah
Journal:  J Orthop Surg Res       Date:  2020-10-28       Impact factor: 2.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.